Navigation Links
One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease
Date:2/18/2009

AUGUSTA, Ga., Feb. 18 /PRNewswire/ -- Taking Control of Your Diabetes (TCOYD) announced findings today from a recent survey conducted by national research firm Yankelovich that found that more than one in five Augustans with type 2 diabetes mistakenly think that excess weight has a positive effect on the disease. In fact, research shows that being overweight often contributes to the development of diabetes, complicates proper management of the disease and can lead to other serious conditions, including blindness, kidney damage and cardiovascular disease.

Survey findings also revealed that the recession is taking a negative toll on how Augustans manage their diabetes. One in four have reduced their level of diabetes care to save money, either by limiting treatment supplies, skipping doctor visits or taking medications less often, which can all lead to significant long-term health risks.

"These findings underscore the need for more education on the importance of proper diabetes management, including the impact of weight, in Augusta and the variety of options available to them," said Dr. Steven Edelman, physician, author and founder of TCOYD.

The survey, which assessed the behaviors and attitudes of Augustans with type 2 diabetes, was commissioned by TCOYD, a not-for-profit 501(c)3 diabetes education organization that offers programs to inform, motivate and empower participants to take control of their diabetes. TCOYD is also holding a diabetes education conference that will help Augustans with diabetes and their loved ones learn how to better manage the disease. The conference and health fair, taking place on Feb. 28, 2009 from 10 a.m. to 4 p.m. at the Augusta Marriott, will feature national and local medical experts in diabetes care discussing the latest developments in the treatment of diabetes, the complications of the disease, psychological barriers to controlling diabetes and nutritional
'/>"/>

SOURCE Taking Control of Your Diabetes
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
2. Novo Nordisk Appoints Andy Ajello as Vice President for National Diabetes Sales, Managed Care and Government Accounts
3. GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
4. Cardiovascular Disease and Diabetes: New Blog and Slide Presentation on the Diabetes Best Practices Website Discuss the Most Recent Studies in this Field
5. PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans
6. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
7. Roche Announces Significant Price Reduction of Two ACCU-CHEK(R) Glucose Monitoring Kits to Help Customers With Diabetes During These Difficult Economic Times
8. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
9. Transition Therapeutics Announces Completion of Patient Enrolment of Phase 2 Study of TT-223 in Type 2 Diabetes Patients
10. dLifeTV Announces New Season Programming and Celebrity Guests; Only Nationally-Broadcast Program About Diabetes Celebrates 5th Year and 200th Show
11. New Diabetes Resource Provides Tools and Support to Families of Newly-Diagnosed Children with Type 1 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...Newswire/ -- The American Medical Association (AMA...Court for the Southern District of New York has gr...osed $350 million settlement that would resolve a ..., The action brought by the AMA, Medical Societ...cal Association, along with several other plaintif...
(Date:12/3/2009)...nimally invasive procedures, study finds , ...lly fatal blood clots after surgery are a much gre...ish study finds. , "What is most striking is th...much longer than people have thought," said Dr. Ja...ity of Oxford and a leader of the team reporting t...
(Date:12/3/2009)...ing of diabetes, cardiovascular disease, researche...ews) -- Pregnant women who develop gestational glu...isk for metabolic syndrome three months after they...ucose intolerance is less severe than gestational ... factors (including high blood pressure, obesity a...
(Date:12/3/2009)...hether they cause brain cancer, , , THU...nes cause brain cancer has been a subject of ongoi...nce suggesting that they don,t. , A 30-year exa...inavia found no substantial change in prevalence e...ing to the report in the Dec. 3 online edition of ...
(Date:12/3/2009)...The day has come. Eight months in the planning, de...re RN organizations will gather in Phoenix Monday,... 150,000-member National Nurses United, the larges...story. ,, AFL-CIO President Richard Trumka will... will chart a course for the building of a more po...
Breaking Medicine News(10 mins):Health News:Settlement in AMA Lawsuit against UnitedHealth Gets Preliminary Approval from Federal Court 2Health News:Blood Clot Threat After Surgery Worse Than Thought 2Health News:Blood Clot Threat After Surgery Worse Than Thought 3Health News:Blood Sugar Intolerance May Predict Postpartum Ills 2Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:RN SuperUnion Founding Convention Opens Monday 2
..., 2009 -- The device looks deceptively simple a p...ket with a spigot but Vinka Craver believes it ca...nt professor of civil and environmental engineerin... becomes safe to drink., "More than one billion ...
...National Safety Council will host a National Poiso... National Poison Prevention Week Council, Tuesday,... Club in Washington, D.C. The event will feature a...duation. Other speakers will include: , , , ,...
...etary of Labor Hilda L. Solis today announced the ...king (ANPRM) for occupational exposure to food fla...ill facilitate the Labor Department,s Occupational...y fatal lung disease associated with such an expos...
... Medical, Inc., manufacturer of the CryoSpray Abla...f its newly redesigned Web site ( www.CSAmedical.c.../prnh/20080721/NEM114LOGO ) , , The Web site fea...e and destroy unwanted tissue in the body. The upd...
...ntertechPira,s 2009 Applications of High-Power Sem...er 15 - 17, 2009 in San Diego, CA , ... Applications of High-Power Semiconductor Lasers (...PSL 2009 will be divided into sectors reflecting i...
..., 2009 A new study published in Epilepsia finds... as high in people with epilepsy compared to the g...al minorities have seven times the odds of depress...ng mental healthcare services. , Data from the 20...
Other Medicine News:Health News:Engineer helps poor in developing nations purify drinking water 2Health News:NSC Hosts National Poison Prevention Week News Conference, Tuesday, March 17 2Health News:U.S. Secretary of Labor Hilda L. Solis takes action to prevent workers' exposure to food flavorings chemical 2Health News:CSA Medical, Inc. Announces Launch of New Web Site for Spray Cryotherapy 2Health News:Call for Presentations: Applications of High-Power Semiconductor Lasers Conference & Exhibit 2Health News:Depression twice as likely in seizure sufferers 2
(Date:12/3/2009)... , WALTHAM, Mass., Dec. 3 Dec...ch and advisory firms focusing on pharmaceutical a...abetes drug market in Brazil will grow from $417 m...ted 15 percent annual growth rate is attributed to...increased use of new generation antidiabetics such...
(Date:12/3/2009)...SAN DIEGO, Dec. 3 Amira Pharmace...a from a Phase 1 clinical study of AM461, the Comp...(also known as CRTH2) receptor. ,, The interi...rmacodynamic (PD) effect can be achieved with AM46...strates a good safety profile. AM461 is a back-up...
(Date:12/3/2009)..., NANJING, China, Dec. 3 /PRNewswire-Asia/ ..."Company") (NYSE: SCR ), a leading pharmaceutica...turing, and marketing of branded,generic and propr...at China,s,State Food and Drug Administration ("SF...nto quality issues regarding human use rabies vacc...
Breaking Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Scientists demonstrate importance of niche differences in biodiversity 9554 1Scientists demonstrate importance of niche differences in biodiversity 9554 2Erik Estrada Accepts Honorary Appointment from Project Lifesaver International 54365 1Erik Estrada Accepts Honorary Appointment from Project Lifesaver International 54365 2Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 1Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 2Sisters of Charity Health System Welcomes Shannon Fogarty Jerse as Deputy General Counsel 54361 3
...n who adhere to a traditional Mediterranean diet -...le grains and fish -- are at a lower risk for stro...y published this week in Circulation: Journal... . , , The research, led by Simmons College Nut...se diets most closely resembled the Mediterranean ...
...ruary 17 Sanofi Pasteur, the,vaccines division of...NY),announced today that it is sponsoring a phase ... difficile, which is among the most common causes ... America. , The trial currently conducted in t...efficacy of sanofi pasteur,s C. difficile candidat...
Other Medicine Technology:Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet 2Risk of Stroke, Heart Disease in Women Lowered by Mediterranean Diet 3Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 2Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 3Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 4Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 5
5.5mm Trephine Handle
10.0mm Calibrated Trephine Handle
8.25mm Calibrated Trephine Handle
6.5mm Calibrated Trephine Handle
Medicine Products: